METASTATIC CERVICAL CANCER
Clinical trials for METASTATIC CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CERVICAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for Tough-to-Treat cervical cancer
Disease control Recruiting nowThis study is testing whether combining two existing drugs, pembrolizumab and lenvatinib, can help control advanced cervical cancer that has worsened after standard treatment. It will involve about 35 women to see if the combination shrinks tumors and for how long. The goal is to…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat cervical cancer
Disease control Recruiting nowThis study is testing whether adding immunotherapy drugs to standard chemotherapy helps women with advanced cervical cancer that has spread, persisted, or returned after previous treatment. It will involve about 120 participants and compare different drug combinations to see whic…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for advanced cervical cancer: trial tests drug combo after standard treatment fails
Disease control Recruiting nowThis study is for people with advanced cervical cancer that has returned or spread and is no longer responding to the immunotherapy drug pembrolizumab. It will test if adding a new investigational drug called PRGN-2009 to pembrolizumab is more effective and safe than continuing p…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC